默沙东安福畅®(克莱罗韦单抗)在华商业上市

格隆汇
Sep 09
据默沙东中国消息,默沙东(MRK.N)于近日宣布,全球首个单一固定剂量长效RSV单抗克莱罗韦单抗注射液已正式在华商业上市,用于即将进入或出生在第一个呼吸道合胞病毒(RSV)流行季的新生儿和婴儿预防RSV所致的下呼吸道感染,无需测量体重,均使用同一剂量进行注射,为中国宝宝带来助力守护呼吸健康的新选择。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10